Navigation Links
Antidepressants-important role

According to a new study, there is no significant difference between three commonly prescribed drugs for depression. The selective serotonin reuptake inhibitors (SSRIs) are now very widely used in the treatment of depression.// They raise levels of a brain chemical called serotonin that plays an important role in mood. But there is no evidence on how individual SSRIs compare with one another. However, a new study by researchers at Cleavland University reveals that there is little difference between three SSRIs - paroxetine, fluoxetine and sertraline.

The study covered nearly 300 patients who took one of the three drugs. More than two thirds of the participants recovered from their depression during nine months of treatment - but it made little difference which drug they were on. This is good news - because individual patients may not respond to one of these SSRIs or find they have side effects. The doctor can now switch them to one of the others, knowing there is a good chance the alternative will produce the desired improvement.


'"/>




Page: 1

Related medicine news :

1. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
2. Pregnancy Blues
3. Smoking Delays Pregnancy
4. Pregnancy weight linked to breast cancer
5. Pregnancy complications indicate health problems
6. Pregnancy shouldnt be dissuaded in older age
7. Ginseng Associated with Pregnancy Risks
8. Predicting The Risk Of Preeclampsia During Pregnancy
9. Drugs Taken During Pregnancy Found To Affect Unborn Babies
10. Complications Of Pregnancy May Increase The Risk Of Cancer
11. Alcohol Consumption During Pregnancy Not Safe
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... The ... industry, today released ten predictions on the future of wellness, travel, spa and beauty ... top travel, spa and beauty companies to leading economists and researchers - to forecast ...
(Date:5/31/2016)... ... ... The Orthopaedic Research and Education Foundation (OREF) is pleased to announce the following ... term as president in March, succeeding John J. Callaghan, MD, who remains on the ... Kyle, MD, will serve as chair, corporate development, succeeding Thomas P. Schmalzried, MD, in ...
(Date:5/31/2016)... ... ... a recent interview on The Greenburgh Report radio show hosted by Greenburgh, NY Town ... leading medical insurance advocate Adria Goldman Gross discussed several eye-opening issues that have combined ... the interview with Mr. Feiner that aired on May 7, 2016, Ms. Gross, the ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet a ... the healthcare industry, The University of Scranton is adding a Certificate in Health ... a career in rapidly growing field of healthcare information. , Healthcare organizations ...
(Date:5/30/2016)... ... May 30, 2016 , ... "This plugin ... said Christina Austin - CEO of Pixel Film Studios. , TransPack Volume ... Pro X. Choose from abstract transitions to more simple wipes with blur & ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 A ... growth is the emergence of new treatments. Cardax, a ... for osteoarthritis treatment. The therapy is expected to fulfil ... Research UK is conducting studies to develop new treatments ... where the genes involved in osteoarthritis are being investigated, ...
(Date:5/26/2016)... 2016 Since its commercial introduction ... essential life science tool for conducting genetic studies in ... reveals in its new report that the industry sits ... powered by a range of new applications in the ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the ...
(Date:5/25/2016)... und GERMANTOWN, Maryland , May ... mit Therawis bedient dringenden ... QIAGEN N.V. (NASDAQ: QGEN ... eine Lizenz- und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH ... Onkologie eingegangen zu sein. Ein erstes Projekt wird ...
Breaking Medicine Technology: